Skip to main content

Table 2 Risk factor values for patients who had above-target values at baseline

From: Cardiovascular secondary prevention in high-risk patients: a randomized controlled trial sub-study

  Intervention Control p-value
LDL-C ≥ 2.5/1.8a baseline, n 87 78  
LDL-C baseline, median (25th–75th percentile) 2.9 (2.6–3.5) 2.9 (2.7–3.7) 0.74
LDL-C 12 months, median (25th–75th percentile) 2.2 (1.8–3.0)*** 3.0 (2.4–3.4)** <0.001
SBP ≥ 140 baseline, n 89 95  
SBP baseline, median (25th–75th percentile) 150 (142–160) 150 (140–160) 0.97
SBP 12 months, median (25th–75th percentile) 140 (129–155)*** 145 (130–158)*** 0.26
DBP ≥ 90 baseline, n 25 26  
DBP baseline, median (25th–75th percentile) 90 (90–95) 90 (90–96) 0.71
DBP 12 months, median (25th–75th percentile) 80 (75–86)*** 80 (75–91)*** 0.48
  1. **p ≤ 0.01, ***p ≤ 0.001, indicating a significant change of median values within each group between baseline and 12 months; a The target LDL-C value was <2.5 mmol/L until 31 March, 2013, when local guidelines for diabetic patients changed this target to <1.8 mmol/L. LDL-C low-density lipoprotein cholesterol (mmol/L), n number of cases, SBP systolic blood pressure (mmHg), DBP diastolic blood pressure (mmHg)